LETTER
Enantioselective Synthesis of Acyclic Pyrrole Carbinols
2423
Mosher ester method, see: Seco, J. M.; Quiñoá, E.; Riguera,
R. Chem. Rev. 2004, 104, 17.
(14) (a) Hasegawa, M.; Taniyama, D.; Tomioka, K. Tetrahedron
2000, 56, 10153. (b) Shindo, M.; Koga, K.; Tomioka, K. J.
Org. Chem. 1998, 63, 9351.
ligand for lithium pyrrolate. The newly formed stereocen-
tre may be used as a stereochemical handle in diastereose-
lective reductions of proximal ketone groups giving
access to either the syn-1,3- or anti-1,3-diol motif depend-
ing on reagent choice. Exploiting the metastability of the
pyrrole carbinol group in a tandem deprotection olefina-
tion sequence affords either enantiomer of the alcohol.
Thus, a stereodivergent strategy is presented where only
one enantiomer of the ligand is required to access either
enantiomer of 13. Other enantioselective approaches to
acyclic pyrrole carbinols and their application in synthesis
are under investigation and will be reported in due course.
(15) (R)-1-Hydroxy-2,2-dimethyl-1-pyrrol-1-yl-pentan-3-one
(2i).
To a rapidly stirred solution of pyrrole (730 mL, 10.5 mmol)
in toluene (100 mL) was added n-BuLi (4.0 mL, 10 mmol,
2.5 M in hexane) at 0 °C. The solution was allowed to warm
to room temperature over 5 min before 7a (2.42 g, 10.0
mmol) was added in one portion. The reaction was allowed
to stir for 25 min at this temperature before cooling to –78 °C
and the aldehyde 1i (1.28 g, 10 mmol) was added over 5 s via
syringe. After 30 min at this temperature the reaction was
quenched by the rapid addition of a pre-cooled solution of
AcOH (15 mmol) in THF (15 mL). After a further 30 min the
reaction was allowed to warm to 0 °C over 15 min before
being filtered though a pad of silica (6 cm × 6 cm) and
concentrated under reduced pressure to give the crude
product. 1H NMR and HPLC analysis indicated a conversion
of 95% and ee of 46%. Purification by flash column
chromatography eluting with hexane–EtOAc (20:1 to 1:5)
yielded 2i as a pale brown oil (1.56 g, 80%), 7a as a white
Acknowledgment
We thank the EPSRC (MSS), AstraZeneca (MSS) and Trinity Col-
lege (MSS) for funding and the National Mass Spectrometry Ser-
vice Swansea for analysis. DJD would like to thank Merck, Sharp
and Dohme, Terlings Park, UK for generous donations to the group.
References
solid (2 g, 70%) together with further 2i (13%) contaminated
(1) Dixon, D. J.; Scott, M. S.; Luckhurst, C. A. Synlett 2003,
2317.
(2) Evans, D. A.; Borg, G.; Scheidt, K. A. Angew. Chem. Int. Ed.
2002, 41, 3188.
25
with 7a (25%). HPLC indicated no change in ee. [a]D
=
+18.2 (c 1.1, CDCl3). 1H NMR (400 MHz): d = 6.71 (2 H, t,
J = 2.2 Hz, CHCHN), 6.13 (2 H, t, J = 2.2 Hz, CHCHN),
5.43 (1 H, br d, J = 3.9 Hz, NCHOH), 4.36 (1 H, br, OH),
2.52–2.41 (2 H, m, CH2), 1.8 (3 H, s, CH3), 1.13 (3 H, s,
CH3), 1.02 (3 H, t, J = 7.1 Hz, CH2CH3). 13C NMR (100
MHz): d = 217.8 (C), 120.3 (CH), 108.2 (CH), 87.8 (CH),
52.4 (C), 32.4 (CH2), 22.9 (CH3), 19.5 (CH3), 7.5 (CH3). IR
(film): nmax = 3445 (br), 2978, 1698, 1472, 1261, 1081 cm–1.
MS (ESI): m/z calcd for C13H13NO+: 196.1332. Found:
196.1335 [MH+].
(3) For similar transformations of N-1¢-hydroxyalkyl-
oxazolidin-2-ones see for example: (a) Bach, J.; Bull, S. D.;
Davies, S. G.; Nicholson, R. L.; Sanganee, H. J.; Smith, A.
D. Tetrahedron Lett. 1999, 40, 6677. (b) Bach, J.; Blachere,
C.; Bull, S. D.; Davies, S. G.; Nicholson, R. L.; Price, P. D.;
Sanganee, H. J.; Smith, A. D. Org. Biomol. Chem. 2003, 1,
2001. (c) Gaul, C.; Seebach, D. Helv. Chim. Acta 2002, 85,
772.
(4) (a) Dixon, D. J.; Lucas, A. C. Synlett 2004, 1092.
(b) Matsunaga, S.; Kinoshita, T.; Okada, S.; Harada, S.;
Shibasaki, M. J. Am. Chem. Soc. 2004, 126, 7559.
(c) Harada, S.; Handa, S.; Matsunaga, S.; Shibasaki, M.
Angew. Chem. Int. Ed. 2005, 44, 4365.
(5) Hoveyda, A. H.; Evans, D. A.; Fu, G. C. Chem. Rev. 1993,
93, 1307.
(6) (a) Comprehensive Asymmetric Catalysis; Jacobsen, E. N.;
Pfaltz, A.; Yamamoto, H., Eds.; Springer: Berlin, 1999.
(b) Asymmetric Catalysis in Organic Synthesis; Noyori, R.,
Ed.; Wiley: New York, 1994.
(16) (a) Freiser, H. Acc. Chem. Res. 1984, 17, 126. (b) Oishi, T.;
Nakata, T. Acc. Chem. Res. 1984, 17, 338.
(17) (1R,3R)-2,2-Dimethyl-1-pyrrol-1-yl-pentane-1,3-diol
(4a).
To a solution of 2i (231 mg, 1.18 mmol) in Et2O (6 mL) was
added freshly prepared zinc borohydride (24 mL, 3.6 mmol,
ca. 0.15 M in Et2O) at –35 °C. After stirring for 8 h the
reaction was quenched with MeOH (5 mL) followed by the
addition of sodium potassium tartrate solution (15 mL) and
EtOAc (25 mL) then stirred for 10 min. The layers were
separated and the aqueous phase further extracted with
EtOAc (2 × 50 mL). The combined organics were washed
with brine (15 mL), dried (MgSO4) and the solvent removed
under reduced pressure. Analysis of the crude material by 1H
NMR gave a selectivity of 94:6. The crude product was
purified by flash column chromatography eluting with
hexane–EtOAc (20:1 to 1:5) gave 4a as a colourless oil (209
mg, 90%) as a 16.6:1 mixture of diastereomers. [a]D25 = +5.2
(c 1.1, CHCl3). 1H NMR (400 MHz, CDCl3): d = 6.81 (2 H,
t, J = 2.0 Hz, CH=CHN), 6.14 (2 H, t, J = 2.0 Hz, CH=CHN),
5.33 (1 H, s, NCHOH), 4.26 (1 H, br, OH), 3.26 [1 H, dd,
J = 10.5, 1.9 Hz, CH(OH)CH2], 2.69 (1 H, br, OH), 1.55 (1
H, dqd, J = 14.1, 7.1, 1.8 Hz, CHaHbCH3), 1.40–1.28 (1 H,
ddq, J = 14.1, 10.5, 7.1 Hz, CHaHbCH3), 1.00 (3 H, s, CCH3),
(7) Organolithiums in Enantioselective Synthesis; Hodgson, D.
M., Ed.; Springer: Berlin, 2003.
(8) (a) Doi, H.; Sakai, T.; Iguchi, M.; Yamada, K.; Tomioka, K.
J. Am. Chem. Soc. 2003, 125, 2886. (b) Doi, H.; Sakai, T.;
Yamada, K.; Tomioka, K. Chem. Commun. 2004, 1850.
(c) Sakai, T.; Doi, H.; Kawamoto, Y.; Yamada, K.;
Tomioka, K. Tetrahedron Lett. 2004, 45, 9261.
(9) See: Granander, J.; Sott, R.; Hilmersson, G. Tetrahedron:
Asymmetry 2003, 14, 439; and references cited therein.
(10) Müller, P.; Allenbach, Y. F.; Bernardinelli, G. Helv. Chim.
Acta 2003, 86, 3164.
(11) Lithium pyrrolate shows low solubility in non-polar
solvents, marginally higher solubility in ethereal solvents.
Almost complete dissolution is observed at the operating
concentration of 0.1 M.
0.98 (3 H, t, J = 7.1 Hz, CH2CH3), 0.67 (3 H, s, CCH3). 13
C
NMR (100 MHz, CDCl3): d = 119.7 (CH), 107.5 (CH), 89.2
(CH), 79.3 (CH), 43.6 (C), 24.2 (CH2), 20.5 (CH3), 14.3
(CH3), 11.0 (CH3). IR (film): nmax = 3399 (br), 2972, 1472,
(12) Ligand 7a was synthesised by the methods of Sharpless and
Tomioka: Wang, Z. M.; Sharpless, K. B. J. Org. Chem.
1994, 59, 8302; and ref. 14.
(13) The absolute stereochemistry of 2a and 2c–i was assigned by
analogy to that of 2b which was established using the
+
1261, 1077, 969 cm–1. MS (ESI): m/z calcd for C11H20NO2 :
198.1489. Found: 198.1492 [MH+].
Synlett 2005, No. 16, 2420–2424 © Thieme Stuttgart · New York